Dr Reddy's hits 52-week high after USFDA issues EIR for Srikakulam facility
Updated : May 08, 2020 12:18 PM IST
Dr Reddy's received the EIR from US health regulator USFDA for its manufacturing plant at Srikakulam.
The drug maker's stock surpassed its previous high of Rs 4,095, touched on April 22, 2020.
The site was issued a warning letter in November 2015 after the inspection in 2014 and was under the "Official Action Indicated" classification till now.
Published : May 08, 2020 12:00 PM IST